A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1
N. Buhlmann et al., A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1, ENDOCRINOL, 140(6), 1999, pp. 2883-2890
Adrenomedullin (ADM) and alpha- and beta-calcitonin (CT) gene-related pepti
de (alpha-, beta CGRP) are structurally related vasodilatory peptides with
homology to CT and amylin. An originally orphan human CT receptor-hire rece
ptor (hCRLR) is a G(s) protein-coupled CGRP or ADM receptor when coexpresse
d with recently identified human single transmembrane domain receptor activ
ity modifying proteins 1 (hRAMP1) or -2 (hRAMP2), respectively. Here, the f
unction of the rat CRLR homologue (rCRLR) has been investigated in rat oste
oblast-like UMR-106 cells and in COS-7 cells, in the absence and presence o
f hRAMP1 and -2 and combinations thereof. Transient expression of rCRLR in
UMR-106 cells revealed an ADM receptor, and [I-125]rat (r) ADM binding was
enhanced with hRAMP2 and inhibited by 50% when hRAMP1 was coexpressed. Dete
ctable [I-125]h alpha CGRP binding required the presence of hRAMP1, and the
expression of CGRP binding sites was unaffected by coexpressed hRAMP2. Spe
cificity of ADM binding sites in [I-125]rADM binding inhibition experiments
was reflected by an over 1000-fold higher potency of rADM [half-maximal ef
fective concentration = 0.19 +/- 0.05 nM (mean +/- SEM, n = 4)], compared w
ith r alpha CGRP and r beta CGRP, to induce a cAMP-responsive luciferase re
porting gene (CRE-luc). In rCRLR and hRAMP1 cotransfected cells, expressing
predominantly CGRP binding sites, r beta CGRP, r alpha CGRP, and rADM indu
ced CRE-luc with half-maximal effective concentration of 0.27 +/- 0.17 nM,
0.37 +/- 0.27 nM, and 1.4 +/- 0.9 nM, respectively. In COS-7 cells, the res
ults were comparable, but rCRLR required coexpressed hRAMP2 for ADM recepto
r function. This is consistent with higher levels of endogenous RAMP2 encod
ing messenger RNA in UMR-106, compared with COS-7 cells. In conclusion, the
recognition of RAMP 1 and -2 as mediators of CRLR expression as a CGRP or
ADM receptor has been extended, with evidence that endogenous RAMP2 is suff
icient to reveal an ADM receptor in UMR-106 cells. Inhibition of RAMP2-evok
ed ADM receptor expression by RAMP1 and generation of a CGRP receptor is co
nsistent with competitive interactions of the different RAMPs with rCRLR.